Flexibility is key for processing sector says Millipore

This content item was originally published on www.biopharma-reporter.com, a William Reed online publication.

By Gareth Macdonald

- Last updated on GMT

Related tags Chemical engineering

Flexibility is going to be a key driver for the pharmaceutical market in the next few years, according to Millipore's VP of downstream processing Paul Chapman.

Chapman spoke with in-PharmaTechnologist at this year's InterPhex trade show in New York, US where the firm launched its Mobius FlexReady range of processing solutions for clarification, buffer and media preparation, tangential flow filtration and virus filtration.

The four platforms use Millipore's Flexware single-use filter assemblies and process-ready hardware to allow pharmaceutical industry clients to rapidly configure and validate their processes, shortening development and manufacturing timelines.

Chapman explained that: "Customers want more flexibility with varied batch sizes, faster processing times and more efficiency in their unit operations.​"

Related news

Show more

Related products

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Follow us


View more